Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elena M. Brozos"'
Autor:
Nieves Martínez-Lago, Ana Fernández-Montes, Marta Covela, Elena M. Brozos, Juan De la Cámara, José C. Méndez Méndez, Mónica Jorge-Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo, David Arias Ron, María L. Pellón Augusto, Paula González Villarroel, Begoña Graña, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López, On behalf of the Galician Research Group on Digestive Tumors (GITuD)
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of
Externí odkaz:
https://doaj.org/article/0205a0ed5fdf486f96be2430c7159205
Autor:
Alberto Carmona-Bayonas, Melina Verso, Manuel Sánchez Cánovas, Jaime Rubio Pérez, Marta García de Herreros, Purificación Martínez del Prado, Isaura Fernández Pérez, Teresa Quintanar Verduguez, Berta Obispo Portero, Vanessa Pachón Olmos, David Gómez, Laura Ortega, Marta Serrano Moyano, Elena M. Brozos, Mercedes Biosca, Maite Antonio Rebollo, Lucía Teijeira Sanchez, Carolina Hernández Pérez, José David Cumplido Burón, Nieves Martínez Lago, Estefanía García Pérez, Jose Muñoz Langa, Pedro Pérez Segura, Eva Martínez de Castro, Paula Jimenez-Fonseca, Giancarlo Agnelli, Andrés Muñoz
Publikováno v:
THROMBOSIS AND HAEMOSTASIS
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Thrombosis and haemostasis
r-FISABIO. Repositorio Institucional de Producción Científica
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Thrombosis and haemostasis
r-FISABIO. Repositorio Institucional de Producción Científica
BACKGROUND: Venous thromboembolism (VTE) is a common complication in cancer patients. Much of its morbidity stems from the development of fatal pulmonary embolisms (PE). Little is known about the factors involved in clot stability, with angiogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39ca449efdd7b5e757437bdd106d877
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1816-8347.pdf
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1816-8347.pdf
Autor:
Nieves Martinez Lago, Ana Fernández Montes, Marta Covela Rúa, Elena M. Brozos Vázquez, Juan C. De la Cámara Gómez, Jose C. Méndez Méndez, Mónica Jorge Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo Rendo, David Arias Ron, Marta Carmona Campos, Yolanda Vidal Insua, Maria L. Pellón Augusto, Paula González Villarroel, Begoña Graña Suarez, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López
Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of antiangi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4516fdfd7ed86ceeb492a6f2d08d1f56
https://doi.org/10.21203/rs.3.rs-79440/v1
https://doi.org/10.21203/rs.3.rs-79440/v1